Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction

Published:2024-02 Issue: Volume:99 Page:129599
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Abdel‐Rahman Somaya A.,Santini Brianda L,Calvo-Barreiro Laura,Zacharias Martin^ORCID,Gabr Moustafa^ORCID

Publisher

Elsevier BV

Reference50 articles.

1. A decade of immune-checkpoint inhibitors in cancer therapy

2. Review of immune checkpoint inhibitors in immuno-oncology

3. Acquired Resistance to Immune Checkpoint Inhibitors

4. Resistance to Checkpoint Inhibition in Cancer Immunotherapy;Barrueto;Transl Oncol,2020

5. Targeting Costimulatory Molecules to Improve Antitumor Immunity

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of glycosaminoglycan binding cyclic peptides using cPEPmatch;Computational and Structural Biotechnology Journal;2024-12

2. cPEPmatch Webserver: A comprehensive tool and database to aid rational design of cyclic peptides for drug discovery;Computational and Structural Biotechnology Journal;2024-12

3. Design and Biophysical Characterization of Second-Generation Cyclic Peptide LAG-3 Inhibitors for Cancer Immunotherapy;2024-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3